Effect of sildenafil on stable chronic heart failure: a prospective randomized-controlled clinical trial
Background Patients with systolic heart failure (HF) who develop secondary pulmonary hypertension have reduced exercise capacity and increased mortality compared with HF patients without pulmonary hypertension. A defective nitric oxide signaling is involved in left ventricular (LV) diastolic abnorma...
Main Authors: | Wael Abdelatief Elhakeem, Hatem Khairy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Medicine in Scientific Research |
Subjects: | |
Online Access: | http://www.jmsr.eg.net/article.asp?issn=2537-091X;year=2019;volume=2;issue=2;spage=118;epage=121;aulast=Elhakeem |
Similar Items
-
Sildenafil improves clinical and functional status of an elderly postmenopausal female with ‘out of proportion’ PH associated with left heart disease
by: Michele Correale, et al.
Published: (2013-12-01) -
Does intravenous sildenafil clinically ameliorate pulmonary hypertension during perioperative management of congenital heart diseases in children? - A prospective randomized study
by: Vipul Krishen Sharma, et al.
Published: (2015-01-01) -
Pulmonary hypertension syndrome in dilation cardiomyopathy patients: sildenafil application to common treatment of chronic heart failure
by: T. A. Abdullaev, et al.
Published: (2016-02-01) -
Pharmacological test with sildenafil at pulmonary hypertension assessing in children with congenital heart diseases
by: O. S. Yanulevich, et al.
Published: (2010-10-01) -
Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study
by: Evgeny Belyavskiy, et al.
Published: (2020-09-01)